Press Release

The Global Agrigenomics Market is projected to grow from USD 3.3 billion in 2021 to USD 6.1 billion by 2030 at a CAGR of 9.7% during the forecast period.

                          Request Free Sample To Learn More About This Report

The exponential increase in population, government initiatives to support research and enhance crop productivity, rise in demand for crop and livestock, and surge in demand for genomic databases by livestock breeders are all expected to propel the agrigenomics market forward during the forecast period. The market is expected to rise due to technological advancements in sequencer systems, such as the development of high-throughput systems and increased automation. Furthermore, the market is expected to rise as the cost of sequencing decreases and the time required for nucleic acid sequencing decreases. Furthermore, as a result of the accuracy of the data, sequencing is becoming increasingly popular. The market is also expected to benefit from ongoing research into market-assisted selection and breeding.

COVID-19 has created significant medical, societal, and economic issues. The agricultural and food processing industries are concentrating their efforts on restoring efficient food production, logistics, and supply chain efficiency, and creating buffer systems to absorb future supply-demand shocks, while the medical community is concentrating on developing effective diagnostic and medical treatment. In addition, trait developers, seed businesses, and genomics researchers and suppliers are attempting to discover capacity-building solutions in the aftermath of the COVID-19 epidemic. Agricultural genomics is progressing toward using gene-editing techniques to generate a variety of antibacterial, antifungal, and antiviral treatments.

Crop genomics research has made a substantial contribution to the successful application of modern molecular biology methodologies to improve species genetics. Because of advances in sequencing technology, the genomes of major crops such as rice, corn, wheat, soybean, rape, vegetables, cotton, and other crops have been sequenced. On this foundation, the cloning and control of genes for critical agronomic features have now been achieved.

                                         Request Free Sample To Learn More About This Report

Rapid innovations in the functional genomics sector, such as the development of approaches and the adoption of massively parallel sequencing technology to efficiently evaluate cellular behavior at the molecular level, are driving the worldwide agrigenomics market. Molecular marker-assisted crop breeding beats traditional breeding methods in terms of crop selection speed, scope, and efficiency. Crops can have improved yield and quality while using fertilizers, fewer pesticides, and water, according to advanced genome characterization methods. This factor is anticipated to propel the global agrigenomics market during the forecast period.        

North America holds the largest market share of agrigenomics due to the R&D, technological innovation, and growing mergers and acquisitions. Because of advances in sequencing and molecular breeding, which are employed in applications such as food and agriculture, animal health, and public health, the United States accounted for the greatest country-level share in 2020. Every year, North American countries generate a considerable amount of GM crops such as canola, corn, soybean, and beet.  

Asia-Pacific is the fastest expanding region in the agrigenomics industry due to the increasing government investment in genomics and crop export. In Japan, agrigenomics research is expanding as research organizations and industry participants collaborate to unravel complicated genetic patterns. 

                                       Request Free Sample To Learn More About This Report

KEY INDUSTRY DEVELOPMENTS:    

In November 2020, LGC announced the addition of a high-resolution mass spectrometer, the SCIEX TripleTOF 6600 LC-MS/MS System, to their regulated bioanalytical LC-MS service.

In November 2019, Thermo Fisher's newly introduced platform, which was released is the first fully integrated next-generation sequencing platform with an automated sample-to-report workflow that delivers results in a single day.

In January 2017, Illumina, Inc. released the NovaSeq S4 flow cell reagent kit and NovaSeq Xp workflow for their NovaSeq 6000 System. The NovaSeq platform's power and versatility are aided by flow cell innovation. The addition of this new flow cell and process to the platform expands its potential.